Media Corner

A new machine learning model developed by the EBMT significantly improves the assessment of transplant risks in patients with myelofibrosis.

The EBMT is proud to announce that its Registry has achieved a landmark milestone of 10,000 chimeric antigen receptor T-cell (CAR-T) therapy patients.

The EBMT proudly commemorates its 50th anniversary, marking five decades of transformative advancements in the field of hematopoietic cell transplantation (HCT) and cellular therapy.

An international team started the research project CERTAINTY in December 2023.

After one year and a half of work, the EBMT launches its new and improved patient Registry database, co-funded by the European Union in a grant called EuroTraCTOR.